Madrid

• A Phase 1b/2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of IM-101 in Adult Participants with Generalized Myasthenia Gr … Recruiting
  2025-522406-20-00 9 2026-06-15 Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
• A clinical study of MK-1045 in people with non-Hodgkin lymphoma (MK-1045-008) Recruiting
  2025-523005-15-00 9 2026-06-15 Non-Hodgkin Lymphoma
• A trial to learn how safe different combinations of anti-cancer drugs are and how well they work in adults with advanced or metastatic non-s … Recruiting
  2025-524843-11-00 4 2026-06-15 Non-Small Cell Lung Cancer
• A clinical trial to learn about the effects of DAK539 on the blood levels of repaglinide, midazolam, drospirenone, and ethinyl estradiol in … Recruiting
  2025-521000-22-00 3 2026-06-12 Patients with advanced malignancies
• A study to evaluate the efficacy and safety of belantamab mafodotin in combination with standard of care in participants aged 18 years and o … Recruiting
  2025-523117-28-00 4 2026-06-12 Relapsed or Refractory Multiple Myeloma
• A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally … Recruiting
  2025-523524-53-00 9 2026-06-12 ADVANCED OR METASTATIC RENAL CELL CARCINOMA
• A Study of Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC Recruiting
  2025-523576-23-00 5 2026-06-12 Unresectable Stage III non-small cell lung cancer without progression
• Study to assess how safe and effective is HRX215 in participants who underwent minor and major liver surgery due to colon carcinoma metastas … Recruiting
  2025-523630-59-00 9 2026-06-12 colon carcinoma metastases
• A Study of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50% Recruiting
  2025-523586-18-00 5 2026-06-11 Non-Small Cell Lung Cancer
• A Phase 3 Study of Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis Recruiting
  2025-524316-11-00 5 2026-06-11 Primary Progressive Multiple Sclerosis (PPMS)
• First time in human (FTIH) study to investigate the safety and preliminary activity of GSK5533524 alone or in combination in adult participa … Recruiting
  2025-524165-25-00 1 2026-06-10 Neoplasms
• Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) (RASolute 304) Recruiting
  2025-523495-23-00 5 2026-06-09 Resected Pancreatic Ductal Adenocarcinoma (PDAC)
• A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorect … Recruiting
  2025-523521-18-00 5 2026-06-09 Metastatic Colorectal Cancer
• A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older with Locally Advanced or Metastatic … Recruiting
  2024-518871-74-00 4 2026-06-08 Locally Advanced or Metastatic Solid Tumours that harbour MET Amplific
• A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indicat … Recruiting
  2025-522362-78-00 6 2026-06-08 severely active ulcerative colitis (US) and CD (Crohn’s disease)
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) - X-CE … Recruiting
  2025-522775-29-00 5 2026-06-05 Depressive episodes associated with Bipolar disorder I or II (Bipolar
• ​​AMG 436 as monotherapy and combination therapy in participants with Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors … Recruiting
  2025-524056-63-00 1 2026-06-05 microsatellite instability high/mismatch repair deficient (MSI-H/dMMR)
• Phase III randomized international open label clinical trial of treatment Intensification with docetaxel plus apalutamide in patients with m … Recruiting
  2025-524408-30-01 5 2026-06-05 Metastatic hormone-sensitive prostate cancer
• PODOMOUNT-Basket, a study to test whether BI 764198 helps adults and adolescents with different types of kidney disease Recruiting
  2025-523425-17-00 4 2026-06-03 Proteinuric kidney diseases
• A Basket Trial of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies Recruiting
  2025-523774-16-00 9 2026-06-03 Advanced malignancies
• A study to test whether different doses of BI 3000202 help people with systemic lupus erythematosus (SLE) Recruiting
  2025-523488-39-00 4 2026-06-02 Systemic lupus erythematosus
• Beamion 44: A study to test how well zongertinib is tolerated by people with advanced non-small cell lung cancer with HER2 mutations when gi … Recruiting
  2025-523567-38-00 4 2026-06-02 locally advanced or metastatic NSCLC
• Open-label Extension of KarXT + KarX-EC for Agitation in Alzheimer’s Disease Recruiting
  2024-519994-20-00 5 2026-06-01 Agitation Associated with Alzheimer’s Disease
• A Study to Learn about the Study Medicine called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive Stage Sma … Recruiting
  2025-523522-41-00 10 2026-06-01 Extensive-Stage Small Cell Lung Cancer

Showing 265–288 of 3,599 trials